Search company, investor...

PhotoSonix Medical

photosonixmed.com

Stage

Private Equity | Alive

Total Raised

$2.39M

Last Raised

$2.39M | 7 yrs ago

About PhotoSonix Medical

PhotoSonix Medical is developing CLENS (Coincident Light Energy and Non-focused ultraSound), a novel energy-based therapy which synergistically combines light and ultrasound to treat chronic bacterial infections known as bio-films.

Headquarters Location

23 Brookline Court

Ambler, Pennsylvania, 19002,

United States

215-641-4909

Missing: PhotoSonix Medical's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: PhotoSonix Medical's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing PhotoSonix Medical

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

PhotoSonix Medical is included in 2 Expert Collections, including Medical Devices.

M

Medical Devices

8,560 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health IT

7,901 items

PhotoSonix Medical Patents

PhotoSonix Medical has filed 1 patent.

The 3 most popular patent topics include:

  • Bacteriology
  • Acoustics
  • Electromagnetic radiation
patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/13/2018

9/7/2021

Acoustics, Sound, Mass spectrometry, Capacitors, Fluid dynamics

Grant

Application Date

3/13/2018

Grant Date

9/7/2021

Title

Related Topics

Acoustics, Sound, Mass spectrometry, Capacitors, Fluid dynamics

Status

Grant

Latest PhotoSonix Medical News

Exclusive: Plans for New Bacteria-Fighting Oral Hygiene Products Will Use This Ft. Washington Company’s Technology

Apr 4, 2019

Ben Franklin Technology Partners from Philadelphia Business Journal | April 4, 2019 A Montgomery County medical device company signed an exclusive licensing agreement Monday that will bring its patented bacteria-fighting technology to the dental industry. Financial terms of the deal between PhotoSonix Medical of Fort Washington and Goldspire Group Ltd., the Hong Kong-based maker of the patented Megasonex brand of ultrasonic toothbrushes and other oral hygiene products, are being kept confidential. PhotoSonix’s technology platform, which involves no medicine, combines ultrasound energy and phototherapy technology to target and destroy undesirable bacteria. The company is initially developing its device as an acne treatment. “We are the only company with a device that can kill bacteria on the skin or in the throat or in the nose,” said Mark E. Schafer, the co-founder and chief technology officer of PhotoSonix. “You may see others claim they do, but there is always an asterisk, and that asterisk will say their device can kill bacteria in a test tube.” The problem with that, Schafer said, is bacteria reacts differently in a person where bacteria has defense mechanisms it employs to survive. PhotoSonix’s CLENS device — which is a little bigger than an electric razor — uses a combination of ultrasound energy to stimulate the chemical compounds in bacteria and photodynamic or blue light therapy to kill the bacteria. Read the full article here . Sign up for our newsletter *

PhotoSonix Medical Frequently Asked Questions (FAQ)

  • Where is PhotoSonix Medical's headquarters?

    PhotoSonix Medical's headquarters is located at 23 Brookline Court, Ambler.

  • What is PhotoSonix Medical's latest funding round?

    PhotoSonix Medical's latest funding round is Private Equity.

  • How much did PhotoSonix Medical raise?

    PhotoSonix Medical raised a total of $2.39M.

  • Who are the investors of PhotoSonix Medical?

    Investors of PhotoSonix Medical include Princeton BioPharma Capital Partners and Ben Franklin Technology Partners of Southeastern PA.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.